Eosinophil granular protein deposits have been demonstrated in lesional atopic dermatitis skin. This suggests active tissue infiltration of eosinophils. To find an explanation for the tissue influx of eosinophils, eosinophil migration was studied in vitro by means of a microchemotaxis assay. Eosinophils from the circulation of patients with atopic dermatitis showed an altered capacity to respond to chemotactic stimuli in vitro compared with eosinophils from healthy donors. Eosinophils from patients with atopic dermatitis had significantly increased migratory responses toward dose ranges of N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activ~tin~ .factor, ~nd platelet factor 4. Eosinophils from normal llldlviduais did not respond to N-formyl-methionyl-leucyl-phenylalanine and neutrophilactivating factor and responded only slightly to platelet factor 4. The migratory responses toward tumor necrosis factora and complement factor CSa were identical in both groups.
Interleukin-5, an eosinophil-selective cytokine, is a strong modulator of the migratory responses to these chemotaxins in eosinophils from normal donors. A migratory response toward N-formyl-methionyl-leucyl-phenylalanine and neutrophil-activating factor was induced by interleukin-5, whereas the migratory response toward platelet-activating factor and platelet factor 4 was markedly potentiated. In contr~st, th~ response to complement fragment CSa was only shghtly lllfluenced. Our findings indicate that the increased mig~atory res~o~siveness. of eosinophils .from patients with atopIc dermatitis to vanous chemotaxllls reflects in vivo "priming" of eosinophils, presumably by circulating cytokin~s such as int~rleukin-S. This in vivo "priming" is not optimal because It can be further potentiated by renewed contact with interleukin-S.] Invest DermatoI100: [137] [138] [139] [140] [141] [142] 1993 infiltrate in the dermis and epidermis showed active infiltration ofT lymphocytes. and eosi~lOphils atthe site of allergen application [5 -7] . Further histochemical analYSIS of the infiltrated eosinophils demonstrated that these cells were in an activated state and had released part ?f their granular conte~lts, in particular eosinophil cationic protell1 [5] . The eosll1ophds disappeared from the dermis and epidermis 72 h after the patcl? test, together with the macroscopically obser:ed eczematous leSIOn [5] . Thereafter, the eosinophil-derived depOSits remall1ed. Careful analysis of the cellular infiltrates of the patch-test reactio~ indicated that other than eosinophils, no other granulocytes had ll1filtrated the skin [5] . Therefore these observations stimulated us to study eosinophil migration in more detail.
111 vi~ro investigati~ns indicate that eosinophils do respond to the followll1g chemotaxll1s: platelet activating factor (PAF), complement fragment C5a, and leukotriene B4 [8, 9] ; however, these chemotaxinsare not selective for eosinophils because they also attract ne~troph.tls. It was recently shown that interleukin (IL)-S acts as an eoslll~pI1l1-~elecuve chemotaxin [10, 11] and promotes the adhesion of eoslllo£lllls, but not of neutrophils, to human endothelial monolayers [12J: We were able to show that eosinophils also do respond chemotactically to relatively high concentrations of the cytokines IL-3 and granulocyte/ macrophage -colony-stimulating factor (GM-CSF). At relatively low concentrations these cytokines are capable of inducing migratory responsiveness toward N-formylmethionyl-leucyl-phenylalanine (FMLP) and neutrophil-activat-0022-202X/93/$06.00 Copyright © 1993 by The Society for Investigative Dermatology, Inc.
137
ing factor (NAF)/IL-8 in eosinophils from normal, healthy individuals [13] . . In atopic dermatitis there is a clear dysfunctlOn of T cells [14] . Recently, activated T cells could be demonstrate~ m the circulation of patients with atopic dermatitis [15] . These actlvated T cells were capable of spontaneously secreting the cytokines IL-3, IL-5, and GM-CSF [15, 16] . T hese cytokines are important modulators of eosinophil function such as migration [13] . . . . We have investigated whether eosmoplllls from patients with atopic dermatitis showed a ~iffere~t migratory response ~o a. v~riety of chemotaxins compared with eosmoplllls from normal mdividuals and whether priming by IL-5 could explain the changed responsiveness.
MATERIALS AND METHODS
Subjects All patients (10 women and 16 men, ages between 17 and 48 years) participating in t. his study. had atopi~ dermatitis as classified according to the cntena of Hal1lfin and RaJka [17] . They were all allergic to three or more different allergens, had positive skin reactions to these allergens, elevated total immunoglobulin (I g) E levels, and positive radio allergo sorbent tests (RASTs) for the relevant allergens. The patients had not taken oral steroids for at least 2 weeks before the study. They were treated only with small amounts of topically applied steroids. All other therapy was stopped at least 2 weeks before the study. At the time of blood collection most patients had mild to moderate eczema; locally active lesions were present. All patients had elevated blood eosinophil levels (> 8%). The normal, healthy volunteers were not allergic, had normal blood eosinophil levels, and did not take any medication. All participating individuals gave their informed consent.
Reagents PAF (1-Q-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine) was purchased from Bache~ Feinchemicalien AG (Bubendorf, Switzerland) . Human recombmant C5a, FMLP, and platelet factor (PF)4 were purchased from Sigma (St. Louis, MO) . Tumor necrosis factor (TNF)-Q was from Cetus Corp. (Emeryville, CA). Ficoll-paque and Percoll were obtained from Pharmacia (U ppsala, Swe~en) . All expenment~ were carried out in Geys' balanced salt solutlOn supplemented with 1.5 mM CaCI 2 , heparin (10 IU/ml), 5 mM glucose, and 1.0% human serum albumin (HSA) (wt/vol) .
cytokines Recombinant hu~an IL-5 . (4 X lOs U/ml) was a kind gift of Dr. C.J. Sanderson (l':!atlOnal Institute for Medical Research, London, U.K.). The molanty of thiS IL-5 preparation was determined by comparison of its potency with commercially available rhIL-5 (Amersham, Buckinghamshire, U .K.; 10 6 U /mg). Recombinant human NAF/IL-8 (1.2 J,lg/ml) was a kind gift from Dr. I. Lindley (Sandoz Forschungsinstitut GmbH, Vienna, Austria) . Stock solutions of the cytokines were prepared in phosphate-buffered saline supplemented with 0.1 % purified HSA and were stored at -70°C until use.
Cell Isolation Blood was obtained from healthy volunteers or from patients with atopic dermatitis. Eosinophils from the blood of normal donors were isolated from the buffy coat of 500 mlofblood, and eosinophils from the patients were isolated from 40 ml of blood anticoagulated with 0.4% (wt/vol) trisodium citrate (pH 7.4), as described previously [1 8] . Briefly, mononuclear cells were removed by separation of blood over isotonic Ficoll Paque (1.077 g/ml, pH 7.4). After isotonic lysis of the erythrocytes in an ice-cold solution containing 155 mM NH 4 CI, 10 mM KHC03 , and 0.1 mM ethylenediaminetetraacetic acid (pH 7.2), the granulocytes were washed and resuspended in RPMI supplemented with HSA (1 % wt/vol) and incubated 30 min at 37°C to restore initial densities of the cells. After this incubatio n period, the cells were washed and resuspended in phosphate-buffered saline supplemented with HSA (1 % wt/vol) and trisodium citrate (0.4% wt/vol). After pre-incubation of the cells for 5 min at 3rC, FMLP (10 nM) was added to the cell suspension, and the incubation was continued for 10 min at 37°C before 1 ml of cell suspension was layered on 4 ml of an isotonic THE JOURNAL OF INVESTIGATIVE DERMATOLOGY Percoll solution (density 1.082 g/ml). To prevent contamination of the cells with cell debris and remaining erythrocytes, 1 ml of Percoil (density 1.100 g/ml) was brought under the Percoll1.082 g/ml solution. After centrifugation (20 min, 1000 X g maximum, room temperature), the eosinophils were collected from the interface. The eosinophils were washed and resuspended in Geys' buffer and kept at room temperature until use. The FMLP treatment does not influence eosinophil function, as is extensively documented elsewhere [13 ,18 -20] . The purity of the cells was always over 90%, and the recovery ranged from 40% to 70%. For comparison, eosinophils were also isolated using the immunomagnetic bead method, as described by Hansel et af [21] . Briefly , Immunomagnetic beads (Dynal Beads, Dyrial A.S., Oslo, Norway) were coated with a monoclonal antibody against CD 16 (CLB FcR gran 1; Central Laboratory of the Red Cross Blood Transfusion, Amsterdam, The Netherlands). These coated beads were coincubated at 4 ° C for 20 min with the granulocyte preparation (10 7 cells/ml) in a ratio of 1: 4 (cells/ beads). The neutrophils were subsequently removed by a magnetic particle concentrator (MPCTH_l; Dynal A.S.).
Migration Assay Migration was measured with a modified Boyden chamber assay using a 48-well microchemotaxis chamber (Neuroprobe, Cabin John, MD) . Chemotaxins or Geys' buffer (30 J,ll) was placed in the lower compartments. Two filters (cellulose nitrate) were placed between the lower and the upper compartments. The lower filter had a pore width of 0.45 J,lm (Millipore type HA; Millipore Corporation, Bedford, MA), and the upper filter had a pore width of 8 J,lm (Sartorius, SM 113; Sartorius AG, Gottingen, Germany) . Before use, the filters were soaked in Geys' buffer. Purified eosinophils, pre-incubated with the tested cytokine (IL-5) or with Geys' buffer for 30 min at 37°C, were placed in the upper compartment (25 J,ll of 5 X 10 6 cells/ml). The chemotaxis chambers were subsequently incubated for 2.5 h at 3rC unless otherwise stated. Hereafter, the upper filters were removed, fixed in butanol/ethanol (20%/80%, v Iv) for 10 min and stained with Weigert solution [1 % hematoxylin (v Iv) in 95% ethanol (v Iv) and an acidic FeCl 3 solution (70 mM) mixed in a volume ratio of 1 : 1]. The filters were dehydrated with ethanol, made transparant with xylene, and fixed upside down. The number of cells per 10 highpower fields was determined with light microscopy (magnification X 400). In this way, the number of cells that had passed the upper filter was determined.
Statistical Analysis All data are presented as mean ± SD. The Student t test for paired or unpaired data was applied; p values < 0.05 were considered significant.
RESULTS
Migratory Responsiveness of Eosinophils from the Circulation of Patients with Atopic Dermatitis and Normal Individuals Toward FMLP, NAF/IL-8, PAF, PF4, TNF-Q, and CSa As is depicted in Fig 1, the eosinophils from patients with atopic dermatitis showed significantly increased migratory responses toward dose ranges of FMLP, NAF/IL-8, PAF, and PF4 compared with eosinophils from normal individuals. These data showed that FMLP and NAF/IL-8 were not chemotactic toward eosinophils from normal individuals. PF4 had only weak chemotactic activity on eosinophils from normal individuals. In contrast, eosinophils from patients with atopic dermatitis showed significant migratory responsiveness toward these chemotaxins. In the case of the PAF-induced chemotaxis, a leftward shift in the responsiveness was present. Eosinophils from patients with atopic dermatitis showed a migratory response to PAF at concentrations approximately 10-11 M . This PAF concentration is not chemotactic for eosinophils from normal individuals. These data are strongly suggestive for "itl vivo" priming of the eosinophils from patients with atopic dermatitis [13J.
In contrast to the FMLP-, NAF/IL-8-, PAF-, and PF4-induced migratory responses, the TNF-Q-and the C5a-induced migratory responses of eosinophils from patients with atopic dermatitis and normal individuals are completely identical. Eosinophils from patients with atopic dermatitis and normal individuals isolated by the two different methods described ([18 ,2 1]; see also Matenals and Methods) responded completely identically to the chemoattractants used here, as shown in Table 1 . The resu lts presented in Table I indicate that the isolation of eosinophils from both normal mdlvlduals and patients with atopic dermatitis are equally influenced by treatment with FMLP or m agnetic beads with respect to the responses studied here.
Influence ofIL-5 on the FMLP-. NAF /IL-S-. P AF-. and PF4-Induced Migratory Response of Isolated Eosinophils from
Normal Individuals. In Fig 1 it is shown that the FMLP-, NAF/ IL-8-, P~F-, an~ PF4-l11d';l~ed m!g ration of eosinophils from patients with atopic dermatitis IS Significantly increased compared with responses of eosl11op hds from normal individuals. We investigated whether priming of eosinophils from normal individuals with IL-S in vitro resulted in a similar effe ct. The results are shown in Table II . Pre-incubation of eosinophils from normal individuals with concentration ranges ofIL-S indeed induced significant migratory responsiveness toward FMLP and NAF/ IL-8, whereas the responses to PAF and PF4 were considerably enhanced. The kinetics of the migratory responses after this it/vitro pre-treatment with IL-S were alm~st similar to those o?served in eosinophils from patients with atopic dermatitis. IL-S pnml11g was irreversible because wash- Table I (6) 30 (7) 39 (10) 71 (12) B PAF 6 36 (7) 36 (7) 44 (8) 57 (10) 100 (18) Atopic Dermatitis 45 (13) 48 (15) (14) 25 (20) 47 ( ing of the cells with cytokine-free buffer did not abrogate priming (data not shown). To show that the above effects. could be specifically ascribed to IL-5, thes~ effects we:e evaluated m the presence of a neutralizing antibody dIrected agamst IL-5 (400 U/ml of IL-5 were neutralized by anti-hu-IL-5, 16 f1g/ml; the antibody was a kind gift of Dr. J. Tavernier, Roche, Ghent, BelglU~). W~en thIs antibody was added together with IL-5 to the eosm~plllls from normal individuals, the "priming" effect for the PAF-mduced response ([PAF] = 1 nM) could be blocked for 87% ± 10% (mean ± SD; n = 4).
Influence of IL-5 on the P AF-and C5a-Induced Migratory Response of Isolated Eosinophils from Patients w.ith Atopic Dermatitis and Normal Individuals Because IL-5 IS capable of "priming" eosinophils from normal individuals ~o respot;d more strongly to certain chemotaxins (e.g., ~AF) a.nd to mduce mlgra~ory responses to others (e.g., FMLP), .we mvestl.g~ted whether eosmohils from patients with atopIc dermatltls could be further R rimed" in their response to PAF and C5a by IL-5 treatment (&L-5] = 1 nM). Indeed, the. responses of these e.os~nophils were potentiated by IL-5, and the m.cre~s~ was almost SImIlar compa~ed with eosinophils from normal mdlvlduals after pre-treatment wIth IL-5 (Fig 2A) . In the case of .C5a-induced migration, only a small potentiation was observed (FIg 2B) .
DISCUSSION
In this report we have shown t~at eos.in.ophils from the.circulation of patients with atopic dermatlt1s exhIbIt potentiated Imgratory responses toward FMLP, NAF/IL-8, PAF: and PF4 compared with eosinophils from normal d.onors: T!le mIgratory responses toward TNF-a and C5a did not dtffer slgmficantly. Recently, we demonstrated that IL-3 and GM-CSF at picomolar concentrations are capable of increasing the migratory responses of eosinophils from normal individuals toward P AF and leukotriene B4 but not to C5a [13] .
On the other hand, pre-treatment with these eytokines is essential for migratory responses toward NAF/IL-8 and FMLP. Here, we show that IL-5 acts in a similar way. Therefore, our findings indicate that eosinophils from patients with atopic dermatitis are present in a "primed" form. Most likely this priming is caused by cytokines, such as IL-3, IL-5, and GM-CSF. Indeed, these cytokines are produced by activated lymphocytes in the circulation of asthma and patients with atopic dermatitis [15, 16] . These findings therefore extend our recent findings on priming mechanisms in allergic asthma [22] . Also, in this allergic disorder the eosinophils are present in a primed state in the .circulation, which might be due to previous exposure to the cytokmes IL-3, IL-5, and GM-CSF [22] . Taken together, our findings extend existing it! vitro evidence that these cytokines may alter a variety ~f eosinophil responses [23] [24] [25] [26] [27] [28] to the in vivo situation (e.g., allergIC asthma and atopic dermatitis [22] ) . Moreover, it has also been. suggested that "pri~ed". eosinophils present at an ~xtravas.cular s~te may exert pa~hoblOloglc effects by responding eaSIly to stlmulatlOn by soluble Itgands and the release of toxic mediators [29] . Although the eosinophils from patients with atopic dermatitis are already in a "primed" state, they can be further potentiated by in vitro contact with IL-5. This suggests that the in vivo "priming" has not been complete.
The eosinophil is not yet considered an important effector cell in atopic dermatitis; however, eosinophilia is regularly observed in active atopic dermatitis [1] . Furthermore, deposits of eosinophilderived mediators such as major basic protein have been reported in lesional atopic dermatitis skin [3] . Patients with atopic dermatitis with elevated circulating IgE levels and positive intracutaneous skin reactions to aeroallergens frequently show a positive patch-test reaction to those allergens [4] . During such a patch-test reaction, which shows a macroscopic and microscopic resemblance to lesional atopic dermatitis skin [5, 6] , eosinophils not only infiltrate but are also activated, causing release of mediators. In earlier reports, we considered the above-mentioned patch-test reaction to aeroallergens in patients with atopic dermatitis an in vivo model to study the pathogenesis of atopic dermatitis [5] . In this model, IgE-bearing Langerhans cells, present in the epidermis and dermis, are considered to present allergen to T cells [30] . These T cells are activated, leading to T-cell proliferation and concomitant cytokine release. Recently, T cells have been cloned from these patch-test reactions, and it has been found that these cells are of the Th2 subtype [31] , producing, among others, IL-4 and IL-5 but not IL-2 or interferon-y [32] . Therefore, T cells can, by the release ofIL-5, contribute to selective eosinophil mobilization; however, other cells present in allergic lesions (e.g., mast cells and endothelial cells) may be activated as well and can therefore also contribute to eosinophil recruitment. Of note, a similar reaction sequence seems to take place in the allergeninduced late-phase skin reaction and the classical delayed-type hypersensitivity reaction [33] . Also, in the allergen-induced late-phase reaction in the skin, activated eosinophils are present in the tissue [33, 34] . The findings reported h~re with ~egar~ to IL-5 prim in? of eosinophils and the consecutive lllcrease III migratory responsiveness toward FMLP, NAF/IL-8, PAF, and PF4 may partly explain the increased infiltration capacity of eosinophils in the patch test reaction and the allergen-induced late-phase reaction. Which of the above-mentioned factors is most important in mobilizing the eosinophils is not yet known because the local concentrations. of the chemotaxins are unknown. These soluble factors may also stimulate the extravasated eosinophils to release toxic mediators [29] . Another interesting possibility is that these tissue eosinophils may contribute to the allergic inflammatory reaction by the release of the abovementioned cytokines themselves. In this way, the eosinophil could amplify the inflammatory response [35] . Taken together, our findings indicate that eosinophils from patients with atopic dermatitis are present in a pre-activated state in the circulation. This is likely to be caused by contact with the cytokines IL-3,.IL-5, .and GM-CSF from act.ivated T c~lls. IL-5 is selective for eoslllophlis and may therefore be Important III modulating/inducing the migratory response of eosinophils toward a variety of chemotaxins formerly thought to be mainly important for neutrophil mobilization.
